SCHEMBL7982730

SCHEMBL7982730

O=C(OCCCCc1ccccc1)c1n[nH]c2ccccc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.68
▸ RAB9A P51151 4/20 0.68
▸ KDM4E B2RXH2 10/20 0.64
▸ HSD17B10 Q99714 2/20 0.62
▸ HPGD P15428 1/20 0.62
▸ MAPK1 P28482 1/20 0.62
▸ MAPT P10636 4/20 0.61
▸ HTT P42858 3/20 0.61
▸ SMN1; SMN2 Q16637 5/20 0.59
▸ ALDH1A1 P00352 4/20 0.57
▸ LMNA P02545 2/20 0.56
▸ NFKB1 P19838 1/20 0.56
▸ NFKB2 Q00653 1/20 0.56
▸ RELA Q04206 1/20 0.56
▸ STAT3 P40763 1/20 0.56
▸ HIF1A Q16665 1/20 0.56
▸ GALR3 O60755 1/20 0.56
▸ MEN1 O00255 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ MAPK10 P53779 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7351475 0.91 NPC1 (0.73) NPC1RAB9AKDM4EHSD17B10HPGD
SCHEMBL6599812 0.83 KDM4E (0.70) NPC1RAB9AKDM4EHSD17B10HPGD
SCHEMBL29687771 0.79 KDM4E (0.71) NPC1RAB9AKDM4EHSD17B10HPGD
SCHEMBL7349354 0.79 KDM4E (0.71) NPC1RAB9AKDM4EHSD17B10HPGD
SCHEMBL4763784 0.78 KDM4E (0.61) NPC1RAB9AKDM4EHSD17B10HPGD
SCHEMBL959364 0.77 KDM4E (1.00) NPC1RAB9AKDM4EHSD17B10HPGD
SCHEMBL29709972 0.77 KDM4E (1.00) NPC1RAB9AKDM4EHSD17B10HPGD
SCHEMBL7348329 0.77 NPC1 (0.65) NPC1RAB9AKDM4EHSD17B10HPGD
SCHEMBL958967 0.77 KDM4E (0.72) NPC1RAB9AKDM4EHSD17B10HPGD
SCHEMBL7982729 0.76 KDM4E (0.56) NPC1RAB9AKDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6214834-B1 ANGIOGENESIS INHIBITORS; ANTIINFLAMMATORY AGENTS; ANTICANCER AGENTS DUPONT PHARMACEUTICALS COMPANY 2001-04-10 — — US disclosed
US-5760028-A TREATING CANCER METASTASIS, DIABETIC RETINOPATHY, NEOVASCULAR GLAUCOMA, THROMBOSIS, RESTENOSIS, OSTEOPOROSIS, MACULAR DEGENERATION THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-02 — — US disclosed
Send feedback